Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
On Feb 19, 2013 we retained Health Management Associates ( HMA - Analyst Report ) at Neutral after the company missed Zacks Consensus Estimate for earnings but beat revenue estimate in the fourth quarter 2012. We continue to have doubts about sustained growth in volumes. Our skepticism is supported by a drop in (same hospital) admissions and volume pressure in the fourth quarter.
Why the Retention?
On Feb 14, Health Management posted fourth-quarter 2012 adjusted earnings of 19 cents per share, missing the Zacks Consensus Estimate of 20 cents per share. Revenues in the reported quarter increased 8.3% year over year to $1,715 million, beating the Zacks Consensus Estimate of $1,686 million.
Over the past 30 days, the Zacks Consensus Estimate for 2013 has moved up by just 3 cents to 87 cents while for 2014 it has inched up by a penny to $1.08 during the same timeframe.
We believe that bad debt may no longer be an area of looming concern. Bad debt expense remained within a band at 13.7% of revenues in the fourth-quarter of 2012, higher than 12.3% in the year-ago quarter. We expect Health Management’s bad debt expense to be restrained in 2013.
Overall, total uncompensated care (the total of uninsured discounts, indigent/charity write-offs, and provision for bad debt as a percentage of adjusted revenue) was on the higher side at 28.7% in fourth-quarter, up from 25.4% in the prior-year quarter.
Other Stocks to Consider
Health Management currently carries a Zacks Rank #3 (Hold). Acadia Healthcare Company, Inc. ( ACHC - Snapshot Report ) carries a Zacks Rank #2 (Buy) and is expected to do well. Furthermore, Merge Healthcare Incorporated ( MRGE - Analyst Report ) retains a Zacks Rank #2 (Buy) and warrants a look.
Read the full reports :
Analyst Report on HMA
Analyst Report on MRGE
Snapshot Report on ACHC